-
Product Insights
Farnesyl Pyrophosphate Synthase (Farnesyl Diphosphate Synthase or (2E,6E) Farnesyl Diphosphate Synthase or Dimethylallyltranstransferase or Geranyltranstransferase or FDPS or EC 2.5.1.10 or EC 2.5.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Farnesyl Pyrophosphate Synthase (Farnesyl Diphosphate Synthase or (2E,6E) Farnesyl Diphosphate Synthase or Dimethylallyltranstransferase or Geranyltranstransferase or FDPS or EC 2.5.1.10 or EC 2.5.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Farnesyl Pyrophosphate Synthase (Farnesyl Diphosphate Synthase or (2E,6E) Farnesyl Diphosphate Synthase or Dimethylallyltranstransferase or Geranyltranstransferase or FDPS or EC 2.5.1.10 or EC 2.5.1.1) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by...
-
Product Insights
Prostatic Acid Phosphatase (5 Nucleotidase or Ecto 5 Nucleotidase or Thiamine Monophosphatase or ACPP or EC 3.1.3.2 or EC 3.1.3.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Prostatic Acid Phosphatase (5' Nucleotidase or Ecto 5' Nucleotidase or Thiamine Monophosphatase or ACPP or EC 3.1.3.2 or EC 3.1.3.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Prostatic Acid Phosphatase (5' Nucleotidase or Ecto 5' Nucleotidase or Thiamine Monophosphatase or ACPP or EC 3.1.3.2 or EC 3.1.3.5) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of...
-
Product Insights
Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of...
-
Product Insights
Diacylglycerol O Acyltransferase 2 (Diglyceride Acyltransferase 2 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT2 or EC 2.3.1.76 or EC 2.3.1.20) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Diacylglycerol O Acyltransferase 2 (Diglyceride Acyltransferase 2 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT2 or EC 2.3.1.76 or EC 2.3.1.20) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Diacylglycerol O Acyltransferase 2 (Diglyceride Acyltransferase 2 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT2 or EC 2.3.1.76 or EC 2.3.1.20) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage...
-
Product Insights
Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule...
-
Product Insights
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development,...
-
Product Insights
Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EPHX2 or EC 3.3.2.10 or EC 3.1.3.76) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EPHX2 or EC 3.3.2.10 or EC 3.1.3.76) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EPHX2 or EC 3.3.2.10 or EC 3.1.3.76) targeted pipeline therapeutics. The...
-
Product Insights
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 or EC 2.7.1.153) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 or EC 2.7.1.153) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 or EC 2.7.1.153)...
-
Product Insights
Cyclin Dependent Kinase 8 (Protein Kinase K35 or Mediator Of RNA Polymerase II Transcription Subunit CDK8 or Cell Division Protein Kinase 8 or Mediator Complex Subunit CDK8 or CDK8 or EC 2.7.11.22 or EC 2.7.11.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Cyclin Dependent Kinase 8 (Protein Kinase K35 or Mediator Of RNA Polymerase II Transcription Subunit CDK8 or Cell Division Protein Kinase 8 or Mediator Complex Subunit CDK8 or CDK8 or EC 2.7.11.22 or EC 2.7.11.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Cyclin Dependent Kinase 8 (Protein Kinase K35 or Mediator Of RNA Polymerase II Transcription Subunit CDK8 or Cell Division Protein Kinase 8 or...
-
Product Insights
DNA (Apurinic or Apyrimidinic Site) Lyase (APEX Nuclease or APEN or Apurinic Apyrimidinic Endonuclease 1 or AP Endonuclease 1 or REF 1 or Redox Factor 1 or APEX1 or EC 4.2.99.18 or EC 3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
DNA (Apurinic or Apyrimidinic Site) Lyase (APEX Nuclease or APEN or Apurinic Apyrimidinic Endonuclease 1 or AP Endonuclease 1 or REF 1 or Redox Factor 1 or APEX1 or EC 4.2.99.18 or EC 3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on DNA (Apurinic or Apyrimidinic Site) Lyase (APEX Nuclease or APEN or Apurinic Apyrimidinic Endonuclease 1 or AP Endonuclease 1 or REF 1 or Redox...